নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 6mg;  ;   - film coated tablet - 6 mg - active: risperidone 6mg     excipient: colloidal silicon dioxide hypromellose   lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc quinoline yellow sodium laurilsulfate sunset yellow fcf titanium dioxide

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 8mg;  ;   - film coated tablet - 8 mg - active: risperidone 8mg     excipient: colloidal silicon dioxide hypromellose indigo carmine lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc quinoline yellow sodium laurilsulfate titanium dioxide

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - golimumab 50mg;   - solution for injection - 50 mg - active: golimumab 50mg   excipient: histidine polysorbate 80 sorbitol water for injection - rheumatoid arthritis: simponi, in combination with mtx, is indicated for: · the treatment of active rheumatoid arthritis in adult patients when the response to dmard therapy has been inadequate. · the treatment of active rheumatoid arthritis in adult patients not previously treated with mtx. simponi has also been shown to reduce the rate of progression of joint damage as measured by x-ray, improve physical function and health related quality of life. simponi can be used in patients previously treated with one or more tnf inhibitor(s).

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - golimumab 50mg;   - solution for injection - 50 mg - active: golimumab 50mg   excipient: histidine polysorbate 80 sorbitol water for injection - rheumatoid arthritis: simponi, in combination with mtx, is indicated for: · the treatment of active rheumatoid arthritis in adult patients when the response to dmard therapy has been inadequate. · the treatment of active rheumatoid arthritis in adult patients not previously treated with mtx. simponi has also been shown to reduce the rate of progression of joint damage as measured by x-ray, improve physical function and health related quality of life. simponi can be used in patients previously treated with one or more tnf inhibitor(s).

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - itraconazole 100mg;   - capsule - 100 mg - active: itraconazole 100mg   excipient: erythrosine gelatin   hypromellose indigo carmine macrogol 20000 sugar spheres titanium dioxide - sporanox capsules are indicated for the following conditions: - treatment of vulvovaginal candidiasis. - treatment of pityriasis versicolor. - treatment of dermatomycosis – including highly keratinised regions as in plantar tinea pedis and palmer tinea manus. - treatment of fungal keratitis. - treatment of oral candidiasis. - treatment of onychomycosis caused by dermatophytes and/or yeasts. - systemic mycoses, only in the following fungal infections: o treatment of systemic aspergillosis and candidiasis, o treatment of histoplasmosis, o histoplasmosis, maintenance therapy only in aids patients. o treatment of sporotrichosis (including lymphocutaneous/cutaneous and extracutaneous), o treatment of paracoccidioidomycosis, o treatment of chromomycosis, o treatment of blastomycosis.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - ustekinumab 45mg;   - solution for injection - 45 mg - active: ustekinumab 45mg   excipient: histidine as hydrochloride polysorbate 80 sucrose water for injection - stelara is indicated for the treatment of adult patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - ustekinumab 90mg;   - solution for injection - 90 mg - active: ustekinumab 90mg   excipient: histidine as histidine hydrochloride polysorbate 80 sucrose water for injection - stelara is indicated for the treatment of adult patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

যুক্তরাজ্য - ইংরেজি - myHealthbox

janssen-cilag ltd - norgestimate, ethinylestradiol - film-coated tablet - 35/ 250 micrograms - hormonal contraceptives for systemic use; progestogens and estrogens, fixed combinations - contraception and the recognised indications for such estrogen/progestogen combinations

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - paliperidone palmitate 312 mg/ml equivalent to 175 mg/dose palperidone, as 273 mg/dose paliperidone palmitate;  ;   - suspension for injection - 175 mg - active: paliperidone palmitate 312 mg/ml equivalent to 175 mg/dose palperidone, as 273 mg/dose paliperidone palmitate     excipient: citric acid monohydrate macrogol 4000 monobasic sodium phosphate monohydrate polysorbate 20 sodium hydroxide water for injection - invega trinza, a 3-month injection, is indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - paliperidone palmitate 312 mg/ml equivalent to 263 mg/dose palperidone, as 410 mg/dose paliperidone palmitate;  ;   - suspension for injection - 263 mg - active: paliperidone palmitate 312 mg/ml equivalent to 263 mg/dose palperidone, as 410 mg/dose paliperidone palmitate     excipient: citric acid monohydrate macrogol 4000 monobasic sodium phosphate monohydrate polysorbate 20 sodium hydroxide water for injection - invega trinza, a 3-month injection, is indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.